About 4 results found for searched term "Umbralisib" (0.124 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M5268 | Umbralisib | PI3K |
| TGR-1202; RP5264 | ||
| Umbralisib (TGR-1202) is an orally active, potent and selective dual PI3Kδ and casein kinase-1-ε (CK1ε) inhibitor, with EC50 of 22.2 nM and 6.0 μM, respectively. | ||
| M14858 | Umbralisib hydrochloride | PI3K |
| TGR-1202 hydrochloride; RP5264 hydrochloride | ||
| Umbralisib hydrochloride (TGR-1202 hydrochloride) is a novel PI3Kδ inhibitor, with IC50 and EC50 of 22.2 nM and 24.3 nM, respectively; Umbralisib hydrochloride (TGR-1202 hydrochloride) is also active against CK1ε, with an EC50 value of 6.0 μM. | ||
| M45296 | Umbralisib sulfate | Casein Kinase |
| TGR-1202 sulfate; RP-5264 sulfate | ||
| Umbralisib sulfate is an orally potent, selective dual inhibitor of PI3Kδ and casein kinase-1-ε (CK1ε) with EC50s of 22.2 nM and 6.0 μM, respectively.Additionally, Umbralisib sulfate has demonstrated unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib sulfate can be used in the study of hematologic malignancies. | ||
| M45298 | Umbralisib tosylate | Casein Kinase |
| TGR-1202 tosylate; RP5264 tosylate | ||
| Umbralisib tosylate is an orally potent, selective dual inhibitor of PI3Kδ and casein kinase-1-ε (CK1ε) with EC50s of 22.2 nM and 6.0 μM, respectively.Additionally, Umbralisib tosylate has demonstrated unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T cells. Umbralisib tosylate Umbralisib tosylate can be used in the study of hematologic malignancies. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
